Laborie Medical Technologies announced that it acquired Pelvalon and its Eclipse non-surgical device for treating fecal incontinence. Redwood City, California-based Pelvalon designed the FDA-cleared Eclipse system as a patient-controlled device for women suffering from fecal incontinence, according to a news release. Portsmouth, New Hampshire-based Laborie was represented by Piper Sandler as financial advisor and Simpson […]
Pelvalon
Burberry poaches Smith & Nephew CFO Brown | Personnel Moves for July 12, 2016
Burberry poaches Smith & Nephew CFO Brown Smith & Nephew (NYSE:SNN) said yesterday that CFO Julie Brown is leaving the company in January 2017 after 4 years on the job at the British healthcare products giant. Brown, who was named finance chief in November 2012 and assumed the role in February 2013, is moving to […]
FDA clears next-gen Pelvalon incontinence device
Pelvalon said yesterday it won FDA 510(k) for its next-generation Eclipse incontinence device designed for women suffering loss of bowel control. Sunnyvale, Calif.-based Pelvalon’s Eclipse is designed to be vaginally inserted, with a balloon that is inflated to put pressure on the rectal wall and prevent involuntary bowel movements. The new version includes a trial insert […]
FDA warns Staar again over Calif. plant | Regulatory news for the week of February 16, 2015
FDA approves Pelvalon’s fecal incontinence device
The FDA’s Center for Devices & Radiological health granted de novo clearance for Pelvalon’s Eclipse system for the treatment of fecal incontinence in women.
